ClinicalTrials.Veeva

Menu

Remote Psychological Intervention for COVID-19 Survivors With AKI and Caregivers (REPICOV-AKI)

J

Jesus Rivero, MD

Status

Completed

Conditions

COVID-19
Depressive Symptoms
Acute Kidney Injury
Anxiety

Treatments

Behavioral: Cognitive behavioral therapy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The frequency of psychological conditions in recovered COVID-19 patients with Acute Kidney Injury (AKI) and their informal primary caregivers (IPC) is unknown; as well as the effects of psychological therapy in this population. The present study was initiated to determine the effectiveness of a brief remote psychological intervention (BRPI) to reduce anxious and depressive symptoms in survivors of AKI.

The investigator designed a single-case experimental design A-B with prospective follow-up. We used the Patient Health Questionnaire-9 (PHQ-9) and the General Anxiety Disorder Scale-7 (GAD-7) to screen for depressive and anxiety symptoms, one week later after hospital discharge. Those with moderate or severe symptoms received cognitive behavioral therapy (CBT) and were evaluated over time with the instruments and daily self-report of symptoms. The statistical analysis was conducted using statistical software.

Enrollment

98 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Survivors of severe COVID-19 who had AKI during hospitalization
  • Informal primary caregivers

Exclusion criteria

  • They did not accept to participate in the study
  • They did not answer three attempted phone calls or text messages making it impossible to complete the intervention.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

98 participants in 1 patient group

Remote cognitive behavioral therapy
Experimental group
Description:
A single-case experimental design A-B with prospective follow-up. We used the Patient Health Questionnaire-9 (PHQ-9) and the General Anxiety Disorder Scale-7 (GAD-7) to screen for depressive and anxiety symptoms, one week later after hospital discharge. Those with moderate or severe symptoms received cognitive behavioral therapy (CBT) and were evaluated over time with the instruments and daily self-report of symptoms.
Treatment:
Behavioral: Cognitive behavioral therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems